We further explored the relationship and interactions between BMP4, cholesterol biosynthesis and statin usage in our preclinical model and in patients, noting that cholesterol has been implicated in breast cancer progression and that cholesterol-lowering statin drugs have been associated with primary and secondary cancer protection. The gene discussed is BMP4; the disease is breast carcinoma.